In this study selenium levels would be determined in both normal volunteers as well as patients suffering from COVID-19.

Not Applicable

Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Registration Number: CTRI/2020/07/026747

Lead Sponsor: Sami Labs Limited

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

A) APPLICABLE FOR NORMAL SUBJECTS

1 Adult male and female between 18 to 45 years of age.

2 For normal subjects who currently have no signs and symptoms of any viral/bacterial infection; Body temperature between 97Âº to 99Âº F and SpO2 > 90%.

3 Literate subject willing to give signed informed consent.

B) APPLICABLE FOR COVIDâ??19 SUBJECTS

1 Adult male and female between 18 to 45 years of age.

2 Confirmed COVID-19 (SARS-CoV-2 ) infection by nasopharyngeal swab RT-PCR test on the same day.

3 COVID-19 patients in stable condition with fever, dyspnea without hypoxemia.

4 Literate subject willing to give signed informed consent.

Exclusion Criteria

A) APPLICABLE FOR NORMAL SUBJECTS

1 Patients participation in any another study including macro/micro/any other forms of dietary supplements/multivitamins or disease specific oral nutrition supplements.

2 Any other condition which the principal investigator thinks may jeopardize the safety of subjects.

B) APPLICABLE FOR COVID -19 PATIENTS

1 Asymptomatic COVID-19 positive patients.

2 On Tube feeding or parenteral nutrition.

3 Admission to isolation ward > 24hrs of confirmed COVID-19 positive test.

4 Patients on ventilator support.

5 Patients whose condition is unstable.

6 Patients participation in any another study including macro/micro/any other forms of dietary supplements/multivitamins or disease specific oral nutrition supplements.

7 Any other condition which the principal investigator thinks may jeopardize the safety of subjects.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1 To analyze the selenium levels in blood and urine of symptomatic COVID-19 positive patients and normal adult subjects. <br/ ><br> <br/ ><br>2 To compare the mean selenium levels in blood and urine of COVID-19 positive patients and normal adult subjects.Timepoint: 1 Selenium levels in blood and urine of symptomatic COVID-19 positive and normal adult subjects (Post enrolment). <br/ ><br> <br/ ><br>2 Mean selenium level comparison in blood and urine of COVID-19 positive and normal adult subjects (Post enrolment).

Secondary Outcome Measures